Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Commercialize quantum technologies in five yearsNature (London), 2017-03, Vol.543 (7644), p.171-174 [Peer Reviewed Journal]COPYRIGHT 2017 Nature Publishing Group ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/543171a ;PMID: 28277529Full text available |
|
2 |
Material Type: Article
|
Virtual Reality in New Product Development: Insights from Prelaunch Sales Forecasting for DurablesJournal of marketing, 2022-05, Vol.86 (3), p.157-179 [Peer Reviewed Journal]The Author(s) 2021 ;ISSN: 0022-2429 ;EISSN: 1547-7185 ;DOI: 10.1177/00222429211014902Digital Resources/Online E-Resources |
|
3 |
Material Type: Article
|
Accelerating innovation: some lessons from the pandemicJournal of Product Innovation Management, 2021-03 [Peer Reviewed Journal]2021. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;DOI: 10.1111/jpim.12565Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trialJournal of hematology and oncology, 2023-02, Vol.16 (1), p.13-13, Article 13 [Peer Reviewed Journal]COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-023-01414-8 ;PMID: 36803531Full text available |
|
5 |
Material Type: Article
|
Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trialJournal of hematology and oncology, 2022-10, Vol.15 (1), p.159-159, Article 159 [Peer Reviewed Journal]COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-022-01369-2 ;PMID: 36316695Full text available |
|
6 |
Material Type: Article
|
Inventing Together: The Role of Actor Goals and Platform Affordances in Open InnovationJournal of the Association for Information Systems, 2022-01, Vol.23 (1), p.264 [Peer Reviewed Journal]Copyright Association for Information Systems Jan 2022 ;ISSN: 1536-9323 ;EISSN: 1536-9323 ;DOI: 10.17705/1jais.00716Full text available |
|
7 |
Material Type: Article
|
0589 Listening to the Patient Voice in Sleep Apnea: Daytime Functioning and Experience with TherapySleep (New York, N.Y.), 2019-04, Vol.42 (Supplement_1), p.A234-A235 [Peer Reviewed Journal]Sleep Research Society 2019. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com. ;ISSN: 0161-8105 ;EISSN: 1550-9109 ;DOI: 10.1093/sleep/zsz067.587Full text available |
|
8 |
Material Type: Article
|
Target product profiles: leprosy diagnostics/ Profil de produit cible: diagnostic de la lepre/ Perfiles de productos objetivo: diagnostico de la lepraBulletin of the World Health Organization, 2024-04, Vol.102 (4), p.288 [Peer Reviewed Journal]COPYRIGHT 2024 World Health Organization ;ISSN: 0042-9686 ;EISSN: 1564-0604 ;DOI: 10.2471/BLT.23.290881Full text available |
|
9 |
Material Type: Article
|
The connection between ADT and evolutionary methods in product developmentJournal of physics. Conference series, 2021-05, Vol.1935 (1), p.12001 [Peer Reviewed Journal]Published under licence by IOP Publishing Ltd ;2021. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1742-6588 ;EISSN: 1742-6596 ;DOI: 10.1088/1742-6596/1935/1/012001Full text available |
|
10 |
Material Type: Article
|
Retracted: Research on Application of 3D Simulation Technology in Industrial Product Design TechnologyAdvances in multimedia, 2023-08, Vol.2023, p.1-1 [Peer Reviewed Journal]Copyright © 2023 Advances in Multimedia. ;Copyright © 2023 Advances in Multimedia. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 ;ISSN: 1687-5680 ;EISSN: 1687-5699 ;DOI: 10.1155/2023/9794286Full text available |
|
11 |
Material Type: Article
|
Research Progress on Active Ingredients and Product Development of ILycium ruthenicum/I MurrayMolecules (Basel, Switzerland), 2024-05, Vol.29 (10) [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;ISSN: 1420-3049 ;EISSN: 1420-3049 ;DOI: 10.3390/molecules29102269Full text available |
|
12 |
Material Type: Article
|
014 The diagnostic odyssey for fabry disease: ten years experience in testingJournal of neurology, neurosurgery and psychiatry, 2018-06, Vol.89 (6), p.A7-A7 [Peer Reviewed Journal]2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2018 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0022-3050 ;EISSN: 1468-330X ;DOI: 10.1136/jnnp-2018-ANZAN.14Full text available |
|
13 |
Material Type: Article
|
Adopting Design Thinking in Novice Multidisciplinary Teams: The Application and Limits of Design Methods and Reflexive PracticesThe Journal of product innovation management, 2013-12, Vol.30 (S1), p.19-33 [Peer Reviewed Journal]2013 Product Development & Management Association ;Copyright Blackwell Publishing Ltd. Dec 2013 ;ISSN: 0737-6782 ;EISSN: 1540-5885 ;DOI: 10.1111/jpim.12061 ;CODEN: JPIMDDFull text available |
|
14 |
Material Type: Article
|
Understanding the Elusive Black Box of Dynamic CapabilitiesDecision sciences, 2011-02, Vol.42 (1), p.239-273 [Peer Reviewed Journal]2011 The Authors Decision Sciences Journal © 2011 Decision Sciences Institute ;Copyright American Institute for Decision Sciences Feb 2011 ;ISSN: 0011-7315 ;EISSN: 1540-5915 ;DOI: 10.1111/j.1540-5915.2010.00287.x ;CODEN: DESCDQFull text available |
|
15 |
Material Type: Article
|
Evolution of the COVID-19 vaccine development landscapeNature reviews. Drug discovery, 2020-10, Vol.19 (10), p.667-668 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Nature 2020. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/d41573-020-00151-8Full text available |
|
16 |
Material Type: Article
|
A Review on Extracts, Chemical Composition and Product Development of Walnut IDiaphragma Juglandis/I FructusFoods, 2023-09, Vol.12 (18) [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;ISSN: 2304-8158 ;EISSN: 2304-8158 ;DOI: 10.3390/foods12183379Full text available |
|
17 |
Material Type: Article
|
Targeted protein degraders crowd into the clinicNature reviews. Drug discovery, 2021-04, Vol.20 (4), p.247-250 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Nature 2021. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/d41573-021-00052-4 ;PMID: 33737725Full text available |
|
18 |
Material Type: Article
|
How to improve new product performance through customer relationship management and product development management: evidence from ChinaThe Journal of business & industrial marketing, 2021-01, Vol.36 (1), p.31-47 [Peer Reviewed Journal]Emerald Publishing Limited ;Emerald Publishing Limited 2020 ;ISSN: 0885-8624 ;EISSN: 2052-1189 ;DOI: 10.1108/JBIM-05-2019-0190Full text available |
|
19 |
Material Type: Article
|
Building trust in multi-stakeholder collaborations for new product development in the digital transformation eraBenchmarking : an international journal, 2021-01, Vol.28 (1), p.205-228 [Peer Reviewed Journal]Emerald Publishing Limited ;Emerald Publishing Limited 2020 ;ISSN: 1463-5771 ;EISSN: 1758-4094 ;DOI: 10.1108/BIJ-04-2020-0164Full text available |
|
20 |
Material Type: Article
|
Trends in clinical success rates and therapeutic focusNature reviews. Drug discovery, 2019-07, Vol.18 (7), p.495-496 [Peer Reviewed Journal]COPYRIGHT 2019 Nature Publishing Group ;Nature 2019. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/d41573-019-00074-z ;PMID: 31267067Full text available |